Bruker (BRKR) Non-Current Deffered Revenue (2010 - 2025)
Bruker (BRKR) posted Non-Current Deffered Revenue of $109.1 million for Q4 2025, up 9.1% on a QoQ basis from $100.0 million in Q4 2024, and up 9.1% year-over-year from $100.0 million in Q4 2024.
Bruker (BRKR) Non-Current Deffered Revenue (2010 - 2025) Analysis & Trends
Bruker's Non-Current Deffered Revenue history runs 16 years deep, the most recent figure standing at $109.1 million for Q4 2025.
- Quarterly Non-Current Deffered Revenue rose 9.1% year-over-year to $109.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $109.1 million (up 9.1% YoY) and the FY2025 annual result came in at $109.1 million, up 9.1% from the prior year.
- Non-Current Deffered Revenue was $109.1 million for Q4 2025 at Bruker, up from $100.0 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $109.1 million in Q4 2025 and bottomed at $50.2 million in Q4 2021.
- A 5-year average of $93.3 million and a median of $97.1 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue jumped 102.39% — and 2023, when it declined 9.94%.
- Bruker's Non-Current Deffered Revenue stood at $50.2 million in 2021, then soared by 102.39% to $101.6 million in 2022, then decreased by 9.94% to $91.5 million in 2023, then climbed by 9.29% to $100.0 million in 2024, then increased by 9.1% to $109.1 million in 2025.
- Business Quant data shows BRKR's Non-Current Deffered Revenue at $109.1 million in Q4 2025, $100.0 million in Q4 2024, and $94.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 109.10 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Sep 30, 2024 | 94.20 Mn |
| Jun 30, 2024 | 93.90 Mn |
| Mar 31, 2024 | 105.60 Mn |
| Dec 31, 2023 | 91.50 Mn |
| Dec 31, 2022 | 101.60 Mn |
| Dec 31, 2021 | 50.20 Mn |
| Dec 31, 2020 | 50.90 Mn |
| Dec 31, 2019 | 42.80 Mn |
| Dec 31, 2018 | 38.30 Mn |
| Dec 31, 2017 | 48.70 Mn |
| Dec 31, 2016 | 46.80 Mn |
| Dec 31, 2015 | 44.40 Mn |
| Dec 31, 2014 | 37.10 Mn |
| Dec 31, 2013 | 33.70 Mn |
| Dec 31, 2012 | 34.90 Mn |
| Dec 31, 2011 | 32.70 Mn |
| Dec 31, 2010 | 29.30 Mn |